1. The Un-audited Financial Results (Standalone and Consolidated) of the Company for the quarter ended June 30, 2026.
2. An expansion plan for Tower IV at the Company's flagship hospital in Sector-51, Gurugram.
Un-audited Standalone Financial Results (Q1 FY27)
The standalone financial results for the quarter ended June 30, 2026, were reviewed by the Audit Committee and approved by the Board. The statutory auditors, T R Chadha & Co LLP, issued an unmodified review conclusion.
Key Financial Figures (₹ in Lakhs):
- Total Income: 28,740.55
- Total Expenses: 24,529.57
- Operative Expenses: 16,519.05
- Employee Benefits Expense: 4,175.93
- Finance Costs: 642.20
- Depreciation and Amortization Expense: 1,235.28
- Other Expenses: 1,957.11
- Profit before exceptional items and tax: 4,210.98
- Exceptional Items (Impact of Labour Code): 1,004.04
- Profit before tax: 3,206.94 (calculated as 4,210.98 - 1,004.04)
- Total Tax Expense: 1,105.87
- Current Tax: 1,004.04
- Earlier Year Tax: 101.83
- Deferred Tax Charge/(Credit): Not separately quantified in the breakdown
- Net Profit after tax: 3,105.11
- Total comprehensive income: 3,101.86
- Paid-up Equity Share Capital (Face value ₹1 each): 1,583.06
- Earnings per Equity Share (₹):
- Basic: 1.96 (not annualized)
- Diluted: 1.96 (not annualized)
Segment Reporting:
The Company has one reportable business segment: "Healthcare Services".
- Revenue from Operations (Geographical - ₹ in Lakhs):
- India: 20,550.45
- Outside India: 7,650.52
- Total: 28,200.97
- Non-Current Assets (Geographical - ₹ in Lakhs):
- India: 1,02,038.47
- Outside India: 0.00
- Total: 1,02,038.47
Un-audited Consolidated Financial Results (Q1 FY27)
The consolidated results include Artemis Medicare Services Limited and its subsidiary, Artemis Cardiac Care Private Limited. The statutory auditors issued an unmodified review conclusion.
Key Financial Figures (₹ in Lakhs):
- Total Income: 29,269.74
- Revenue from Operations: 28,732.35
- Other Income: 537.39
- Total Expenses: 25,006.70
- Operative Expenses: 16,776.44
- Employee Benefits Expense: 4,283.64
- Finance Costs: 645.99
- Depreciation and Amortization Expense: 1,272.77
- Other Expenses: 2,027.86
- Profit before exceptional items and tax: 4,263.04
- Exceptional Items (Impact of Labour Code): 0.00 (for the quarter; ₹307.44 for the year ended Mar-26)
- Profit before tax: 4,263.04
- Total Tax Expense: 1,118.77
- Current Tax: 1,004.04
- Earlier Year Tax: 0.00 (for the quarter; (13.83) for the year ended Mar-26)
- Deferred Tax Charge/(Credit): 114.73
- Net Profit after tax: 3,144.27
- Attributable to Shareholders of the Company: 3,131.07
- Attributable to Non-Controlling Interest: 13.21
- Total comprehensive income: 3,140.61
- Attributable to Shareholders of the Company: 3,127.54
- Attributable to Non-Controlling Interest: 13.07
- Paid-up Equity Share Capital (Face value ₹1 each): 1,583.06
- Earnings per Equity Share (₹):
- Basic: 1.98 (not annualized)
- Diluted: 1.98 (not annualized)
Subsidiary Information (Artemis Cardiac Care Private Limited):
- Total Assets as of June 30, 2026: ₹2,260.47 Lakhs
- Total Revenue for the quarter: ₹532.06 Lakhs
- Net Profit after Tax for the quarter: ₹37.75 Lakhs
- Total Comprehensive Income for the quarter: ₹37.33 Lakhs
Segment Reporting (Consolidated):
The Group has one reportable business segment: "Healthcare Services".
- Revenue from Operations (Geographical - ₹ in Lakhs):
- India: 21,081.83
- Outside India: 7,650.52
- Total: 28,732.35
- Non-Current Assets (Geographical - ₹ in Lakhs):
- India: 1,03,160.79
- Outside India: 0.00
- Total: 1,03,160.79
Funding and Capital History
Pursuant to Board and shareholder approval in April/May 2024, the Company issued 33,000 CCDs aggregating ~₹33,000 Lakhs to International Finance Corporation (IFC) by way of a preferential issue. These CCDs converted into 1,89,62,247 equity shares on November 15, 2025. Out of the total proceeds, ₹5,434 Lakhs (including ₹745 Lakhs in Q1 FY27) have been utilized towards expansion, with the balance held in fixed deposits.
Expansion Plan (Tower IV, Gurugram)
The Board approved a capacity expansion plan for the flagship hospital in Sector-51, Gurugram, detailed in Annexure A as per Regulation 30 and Schedule III of SEBI LODR.
Details of the Expansion:
- Existing Capacity: ~800 beds in Delhi NCR and ~300 beds in Raipur, Chhattisgarh. The Vimhans Artemis Hospital in Nehru Nagar, New Delhi, is expected to commence operations by FY29 with 650+ beds.
- Existing Capacity Utilization: 65.7% for Artemis Hospital in Q1 FY27.
- Proposed Capacity Addition: 200+ beds dedicated to quaternary pediatric care and advanced gynecology & women's health services.
- Implementation Timeline: ~2 years.
- Investment Required: ₹160 - 180 Crore.
- Mode of Financing: Through internal accruals and debt financing.
- Rationale: To address growing demand for specialized pediatric care (neonatal, pediatric ICU, super-specialty, surgery) and advanced gynecology (high-risk pregnancies, maternal-fetal medicine, genetics, reproductive medicine, gynecologic oncology, urology, wellness services). The expansion aims to enhance capacity in the Delhi NCR region and support long-term revenue growth.